Loading...
Sysmex Corporation
SSMXF•PNK
Healthcare
Medical - Instruments & Supplies
$15.80
$0.50(3.27%)
Sysmex Corporation (SSMXF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Sysmex Corporation (SSMXF), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
10.21%
↑ 10.21%
Operating Income Growth
14.41%
↑ 14.41%
Net Income Growth
8.12%
↑ 8.12%
Operating Cash Flow Growth
38.09%
↑ 38.09%
Operating Margin
17.22%
↑ 17.22%
Gross Margin
53.47%
↑ 53.47%
Net Profit Margin
10.55%
↑ 10.55%
ROE
11.82%
↑ 11.82%
ROIC
16.15%
↑ 16.15%
Sysmex Corporation (SSMXF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Sysmex Corporation SSMXF financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $141.78B | $124.39B | $130.53B | $111.95B |
| Cost of Revenue | $68.61B | $56.87B | $59.28B | $51.91B |
| Gross Profit | $73.17B | $67.52B | $71.25B | $60.04B |
| Gross Profit Ratio | $0.52 | $0.54 | $0.55 | $0.54 |
| R&D Expenses | $8.91B | $7.30B | $7.88B | $7.36B |
| SG&A Expenses | $40.88B | $37.60B | $36.35B | $36.02B |
| Operating Expenses | $49.79B | $44.90B | $44.24B | $43.37B |
| Total Costs & Expenses | $118.40B | $101.78B | $103.52B | $95.28B |
| Interest Income | $318.00M | $240.00M | $0.00 | $213.00M |
| Interest Expense | $1.34B | $760.00M | $831.00M | $590.00M |
| Depreciation & Amortization | $10.33B | $9.51B | -$4.37B | $9.79B |
| EBITDA | $29.45B | $32.35B | $32.06B | $26.53B |
| EBITDA Ratio | $0.21 | $0.26 | $0.25 | $0.24 |
| Operating Income | $23.38B | $22.61B | $27.02B | $16.67B |
| Operating Income Ratio | $0.16 | $0.18 | $0.21 | $0.15 |
| Other Income/Expenses (Net) | -$5.61B | $901.00M | -$5.20B | $312.00M |
| Income Before Tax | $17.77B | $23.51B | $21.82B | $16.98B |
| Income Before Tax Ratio | $0.13 | $0.19 | $0.17 | $0.15 |
| Income Tax Expense | $6.35B | $6.94B | $6.36B | $6.00B |
| Net Income | $11.05B | $16.61B | $14.97B | $11.03B |
| Net Income Ratio | $0.08 | $0.13 | $0.11 | $0.10 |
| EPS | $17.73 | $26.63 | $23.84 | $17.69 |
| Diluted EPS | $17.72 | $26.63 | $23.83 | $17.69 |
| Weighted Avg Shares Outstanding | $623.60M | $623.77M | $627.91M | $623.57M |
| Weighted Avg Shares Outstanding (Diluted) | $623.60M | $623.77M | $628.11M | $623.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan